Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8968196Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
- Pathology
NIH Funding · FY2025
Linked Award Amount
$1.9M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#7,236
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Huiping Liu as a PI. Multi-PI records show the full award amount for context.
- 5R01AI167272-04R01Clinical analysis and therapeutic development of exosomal ACE2$697.5Kaward amount
- 1R01CA288387-01A1R01Develop a novel therapy with immuno- and onco-targeting dual efficacies to treat the triple negative breast cancer$661.1Kaward amount
- 1R01CA298232-01A1R01Novel functions of PlexinB2 in circulating tumor cell clusters$546Kaward amount
Award organization
Organizations that administered FY2025 awards listing Huiping Liu as a PI.
FY2025 award administered by Northwestern University (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNorthwestern University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7236
- 2025R01 Grant Holder
- 2026Entered Top 25% NationallyRanked #3594
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Huiping Liu.